Skip to content
Open access

Platelet-Related Signature in Colorectal Cancer: Prognosis and Therapy Guidance

Sep 2026 · International Journal of Molecular Sciences · Vol 27, pp. 8312 · 0 citations · 43 references
Medicine

TL;DR

The PLRS model demonstrated statistically significant prognostic value and may serve as a complementary tool for CRC risk stratification, providing a basis for further investigation into platelet-related transcriptional programs.

Abstract

Platelets are key components of the tumor microenvironment that contribute to colorectal cancer (CRC) progression. However, effective platelet-related prognostic tools for CRC risk stratification and prognostic assessment are lacking. Therefore, we aimed to develop a platelet-related prognostic model to improve risk stratification and prognostic evaluation. A tumor-cell-expressed platelet-related transcriptional signature, termed platelet-related risk score (PLRS), was established using LASSO and Cox regression based on TCGA-COADREAD, GSE39582 and GSE183635. After strict screening for intact survival information, 573, 531 and 85 tumor samples were retained correspondingly. Patients were stratified into high- and low-PLRS groups according to the median cutoff value of PLRS derived from the training cohort. A single-cell dataset GSE178341 was utilized for single-cell transcriptomic validation. All analyses were performed in R. Wilcoxon test, Kaplan–Meier method, log-rank test, multivariate Cox regression and ROC curves were applied with two-sided p < 0.05. qRT-PCR was conducted for hub gene validation. The PLRS model involved six prognostic genes (TIMP1, TTYH3, GPX4, PLCB4, CA2, and LITAF). The high- and low-PLRS groups showed significant differences in disease stage and survival in TCGA datasets, which was confirmed in the GEO dataset (GSE39582). The multivariate analysis established the PLRS as an independent prognostic factor. Single-cell analyses revealed distinct transcriptional trajectories, immune microenvironments, and communication patterns between the PLRS groups. Stromal, immune, and ESTIMATE scores positively correlated with PLRS, whereas tumor purity was inversely correlated. Exploratory drug sensitivity analysis using GDSC and CCLE cell line datasets suggested potential associations between PLRS and multiple therapeutic agents, warranting validation in clinical cohorts. qRT-PCR in RKO cells compared with the CCD-18Co fibroblast control partially confirmed the expression trends of four PLRS genes (TIMP1, GPX4, LITAF, and PLCB4), whereas TTYH3 showed no significant difference and CA2 was not tested due to primer-design failure. Validation in normal colonic epithelial cells is warranted. The PLRS model demonstrated statistically significant prognostic value and may serve as a complementary tool for CRC risk stratification, providing a basis for further investigation into platelet-related transcriptional programs.

Read PDF

Similar papers

Open access Sep 2026

Neutrophil-related gene signature predicts prognosis and immune microenvironment patterns in thyroid cancer.

BACKGROUND Thyroid carcinoma (THCA) represents the most prevalent malignancy of the endocrine system. Although the majority of patients exhibit favorable clinical outcomes, a subset still faces significant clinical challenges, including distant metastasis, recurrence, and poor response to therapeutic interventions, all...

Liang Chen, Chao-Hon Fu, Yang Chen et al. · 0 citations
Open access Nov 2026

A prognostic model based on platelet-related genes accurately predicts survival in patients with gastric cancer

Background Platelets contribute to gastric cancer (GC) progression and metastasis. In this study, we aimed to construct a prognostic model based on platelet-related genes (PRGs) to predict outcomes in GC. Methods RNA sequencing data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were analyzed to...

Chuang Zheng, Wei-Feng Yang, Qiu-Lian Lu et al. · 0 citations
Open access Oct 2026

A tumor-infiltrating lymphocyte-related prognostic signature for lung adenocarcinoma

Background Tumor-infiltrating lymphocytes (TILs) have been reported to be associated with prognosis in lung adenocarcinoma (LUAD). Effective prognostic models for LUAD remain limited, and more robust biomarkers for risk stratification are still needed. Effective TILs prognostic models for LUAD remain limited, and this...

Kang Tian, Xin-Jie Zhao, Jia-Jun Du et al. · 0 citations
Open access Oct 2026

COMP and CXCL10: a novel immunogenic cell death-derived gene signature for prognostic prediction in colorectal cancer

This study identified COMP and CXCL10 as significantly expressed prognostic genes in colorectal cancer and introduced a novel immune cell death-associated prognostic model that exhibited consistent predictive reliability across both training and validation datasets.

Rui-Long Tang, Y. Li, Min Liu et al. · 0 citations
Open access Oct 2026

Construction of a GCSCs-Related Prognostic Risk Model Based on Transcriptomic Data

Gastric Cancer Stem Cells (GCSCs) contribute to tumor progression and treatment resistance, but their heterogeneity and tumor microenvironment interactions remain unclear. We analyzed GSE163558 single-cell RNA-sequencing data from 10 gastric cancer samples and integrated GCSC-related genes with The Cancer Genome Atlas...

Xin Hu, Shi-Qi Fan, Nai-Qiang Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.